GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical Endocrinology, Wiley, Vol. 96, No. 6 ( 2022-06), p. 918-921
    Type of Medium: Online Resource
    ISSN: 0300-0664 , 1365-2265
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2022
    detail.hit.zdb_id: 2004597-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Wiley ; 2023
    In:  Clinical Endocrinology Vol. 98, No. 1 ( 2023-01), p. 3-13
    In: Clinical Endocrinology, Wiley, Vol. 98, No. 1 ( 2023-01), p. 3-13
    Abstract: Obstructive sleep apnoea (OSA) is a common disorder characterized by recurrent episodes of apnoea or hypopnea due to total or partial pharyngeal collapse and temporary upper airway obstruction during sleep. The prevalence of OSA is increasing and currently affects about 30% of men and 13% of women in Europe. Intermittent hypoxia, oxidative stress, systemic inflammation, and sleep fragmentation resulting from OSA can provoke subsequent cardiometabolic disorders. The relationships between endocrine disorders and OSA are complex and bidirectional. Indeed, several endocrine disorders are risk factors for OSA. Compared with the general population, the prevalence of OSA is increased in patients with obesity, hypothyroidism, acromegaly, Cushing syndrome, and type 1 and 2 diabetes. In some cases, treatment of the underlying endocrine disorder can improve, and occasionally cure, OSA. On the other hand, OSA can also induce endocrine disorders, particularly glucose metabolism abnormalities. Whether continuous positive airway pressure (CPAP) treatment for OSA can improve these endocrine disturbances remains unclear due to the presence of several confounding factors. In this review, we discuss the current state‐of‐the‐art based on the review of the current medical literature for key articles focusing on the bidirectional relationship between endocrine disorders and OSA and the effects of treatment. Screening of OSA in endocrine patients is also discussed, as it remains a subject of debate.
    Type of Medium: Online Resource
    ISSN: 0300-0664 , 1365-2265
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2004597-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Clinical Endocrinology, Wiley, Vol. 86, No. 6 ( 2017-06), p. 830-836
    Abstract: Guidelines on the management of thyroid dysfunction during pregnancy have recently been updated and, for the diagnosis of subclinical hypothyroidism ( SCH ), a thyroid‐stimulating hormone ( TSH ) upper reference limit (cut‐off) of 4.0  mIU /L has been proposed when no institutional values are available. It is also suggested that serum TSH and thyroid autoimmunity ( TAI ) may be different according to the ethnic background of the women. We therefore determined the prevalence of TAI and SCH in pregnant women with different ethnic backgrounds and, to define SCH , we used different first trimester TSH upper reference cut‐offs (institutional, ethnicity‐specific, 2.5  mIU /L [Endocrine Society] and 4.0  mIU /L [American Thyroid Association]). Design Cross‐sectional data analysis of 1683 pregnant women nested within an ongoing prospective database of pregnant women. Method The study was performed in a single centre in Brussels, Belgium. During the first antenatal visit, thyroid peroxidase antibodies ( TPO ‐abs), TSH and free T4 ( FT 4) were measured and baseline characteristics recorded. Data from 481 women with sub‐Saharan (SaBg; 28.6%), 754 North African (NaBg; 44.8%) and 448 Caucasian (CaBg; 26.6%) backgrounds were analysed. For the calculation of TSH reference ranges, women with TAI , outliers, twin and assisted pregnancies were excluded. Results The prevalence of TAI was significantly lower in the SaBg group than in NaBg and CaBg groups (3.3% vs 8.6% and 11.1%; P 〈 .001, respectively). Median TSH was significantly lower in SaBg and NaBg groups as compared with the CaBg group (1.3 and 1.4 vs 1.5 mIU /L; P =.006 and .014, respectively). The prevalence of women with SCH was comparable between all groups when 2.5 mIU /L was used as cut‐off, but when 4.0  mIU /L or the institutional cut‐off (3.74  mIU /L) was used, it was significantly higher in the CaBg group vs the NaBg group (5.4% vs 2.1% and 7.1% vs 3.3%, P =.008 and .013, respectively). The use of ethnicity‐specific cut‐offs did not change the prevalence of SCH as compared to the use of institutional cut‐offs. However, when these cut‐offs were used, the prevalence of SCH reduced by 〉 70% (4.5% instead of 16.7%; P 〈 .001) relative to the 2.5  mIU /L cut‐off. Conclusions Pregnant women with a sub‐Saharan African background had a lower prevalence of TAI and TSH levels as compared with women from other backgrounds. The use of ethnicity‐specific TSH cut‐offs in early pregnancy was not more specific for the diagnosis of SCH as compared to the use of the institutional cut‐off.
    Type of Medium: Online Resource
    ISSN: 0300-0664 , 1365-2265
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2017
    detail.hit.zdb_id: 2004597-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...